GTF2I and Werner syndrome: AAV-based post-natal Gtf2i gene therapy in a mouse model of WS in which there is complete pre-natal deletion of the WSCR resulted in the restoration of mouse (m)Gtf2i levels, alongside improved motor coordination and sociability, as well as decreased anxiety, as compared to controls [22].